PolyPid (PYPD) Competitors

PolyPid (NASDAQ:PYPD) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

Is PYPD or CVRX more profitable?

PolyPid has a net margin of 0.00% compared to CVRx's net margin of -95.61%. CVRx's return on equity of -79.31% beat PolyPid's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PolyPid	N/A	-453.95%	-138.92%
CVRx	-95.61%	-79.31%	-40.96%

Does the media favor PYPD or CVRX?

In the previous week, PolyPid had 8 more articles in the media than CVRx. MarketBeat recorded 10 mentions for PolyPid and 2 mentions for CVRx. CVRx's average media sentiment score of 1.48 beat PolyPid's score of -0.24 indicating that CVRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PolyPid	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
CVRx	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, PYPD or CVRX?

PolyPid has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, CVRx has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500.

Do analysts prefer PYPD or CVRX?

PolyPid currently has a consensus price target of $12.40, indicating a potential upside of 254.29%. CVRx has a consensus price target of $14.00, indicating a potential upside of 79.49%. Given PolyPid's stronger consensus rating and higher possible upside, research analysts plainly believe PolyPid is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PolyPid	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17
CVRx	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

Which has higher earnings & valuation, PYPD or CVRX?

PolyPid has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PolyPid	N/A	N/A	-$29.02M	-$3.83	-0.91
CVRx	$54.65M	3.73	-$59.97M	-$2.10	-3.71

Do insiders & institutionals believe in PYPD or CVRX?

26.5% of PolyPid shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 24.7% of PolyPid shares are held by insiders. Comparatively, 13.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

PolyPid beats CVRx on 8 of the 14 factors compared between the two stocks.